Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia

Current Opinion in Critical Care

Volumn 20, Issue 5, 2014, Pages 525-531

  Rouzéa, Anahita ^a   Cottereaua, Aurélie ^a   Nseir, Saad ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic obstructive pulmonary disease; Intensive care; Lower respiratory tract colonization; Microaspiration; Ventilator associated pneumonia

Indexed keywords

CORTICOSTEROID;

ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; DIAPHRAGM MUSCLE; GASTROESOPHAGEAL REFLUX; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; LUNG ASPIRATION; MALNUTRITION; MICROBIOLOGY; NEBULIZER; PATHOGENESIS; REVIEW; RISK FACTOR; SWALLOWING; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA; WEAKNESS; ADVERSE EFFECTS; COMPLICATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LUNG; PATHOPHYSIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATORY SYSTEM;

GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOSUPPRESSION; LUNG; PNEUMONIA, VENTILATOR-ASSOCIATED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY SYSTEM; RISK FACTORS;

EID: 84916878548     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000123     Document Type: Review

References (66)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
2. World Health Organization. World health statistics 2008. Available from: http//www.who.int/gho/publications/world-health-statistics/EN-WHS08-Full.pdf?ua=1. [Accessed 3 May 2014]
3. Funk G-C, Bauer P, Burghuber OC, et al. Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008. Eur Respir J 2013;41:792-799. A large Austrian cohort describing the epidemiology of COPD in critically ill patients.
4. Esteban A, Frutos-Vivar F, Muriel A, et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med 2013;188:220-230. An epidemiological comparison of the largest worldwide prospective cohorts conducted in 1998, 2004, and 2010, including over 18 000 patients from more than 900 ICUs, receiving mechanical ventilation for more than 12 h.
5. Stefan M, Nathanson B, Jay S, et al. Characteristics, managements, and outcomes of patients hospitalized to intensive care unit with an acute exacerbation of COPD in US 2008-2012. Chest 2014;145(Suppl 3):382A.
6. Muscedere J, Sinuff T, Heyland DK, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest 2013;144:1453-1460. An interesting epidemiological analysis of the relationship between ventilator-associated conditions or infection-related ventilator-associated complications and VAP.
7. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. Am J Infect Control 2011;39:349-367.
8. European Center for Disease Prevention and Control: Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. Stockholm: ECDC, 2011. http://www.ecdc.europa.eu [Accessed 3 May 2014]
9. Rosenthal VD, Rodrigues C, Álvarez-Moreno C, et al. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: findings of the International Nosocomial Infection Control Consortium. Crit Care Med 2012;40:3121-3128.
10. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-528.
11. Gursel G. Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit. Respiration 2005;72:61-67.
12. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005;128:1650-1656.
13. Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006;21:56-65.
14. Al-Dorzi HM, El-Saed A, Rishu AH, et al. The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control 2012;40:794-799.
15. Makris D, Desrousseaux B, Zakynthinos E, et al. The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia. Respir Med 2011;105:1022-1029.
16. Nseir S, Di Pompeo C, Cavestri B, et al. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 2006;34:2959-2966.
17. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005;50:725-741.
18. Hunter JD. Ventilator associated pneumonia. BMJ 2012;344:e3325.
19. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilatorassociated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440.
20. Mendez-Tellez PA, Needham DM. Early physical rehabilitation in the ICU and ventilator liberation. Respir Care 2012;57:1663-1669.
21. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-88.
22. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013;45:2245-2256.
23. Nseir S, Ader F, Lubret R, Marquette CH. Pathophysiology of airway colonization in critically ill COPD patient. Curr Drug Targets 2011;12:514-520.
24. Nseir S, Zerimech F, Jaillette E, et al. Microaspiration in intubated critically ill patients: diagnosis and prevention. Infect Disord Drug Targets 2011;11:413-423.
25. Dewavrin F, Zerimech F, Boyer A, et al. Accuracy of alpha amylase in diagnosing microaspiration in intubated critically-ill patients. PLoS One 2014;9:e90851. A study aiming to evaluate the accuracy of a-amylase in diagnosing microaspiration, assessed by pepsin quantitative measurement in tracheal aspirates, in critically ill patients.
26. Lee AL, Button BM, Denehy L, et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology 2013. [Epub ahead of print] A prospective observational study assessing GER and gastric aspiration in patients with COPD or bronchiectasis.
27. Metheny NA, Clouse RE, Chang Y-H, et al. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006;34:1007-1015.
28. Patel ARC, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011;5:647-662.
29. Kamble NL, Khan NA, Kumar N, et al. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology 2013;18:463-467. A prospective study of incidence and pattern of GER in COPD patients using dualprobe 24-h esophageal pH recording.
30. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
31. Liang B, Wang M, Yi Q, Feng Y. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease. Dis Esophagus 2013;26:557-560. A study exploring the association between GER disease risk and exacerbations of COPD.
32. Gadel AA, Mostafa M, Younis A, Haleem M. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology 2012;59:2498-2502.
33. Liang BM, Feng YL. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung 2012;190:277-282.
34. Ari A, Fink JB, Dhand R. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012;25:319-332.
35. Jaillette E, Nseir S. Relationship between inhaled b2-agonists and ventilatorassociated pneumonia: a cohort study. Crit Care Med 2011;39:725-730.
36. Cvejic L, Harding R, Churchward T, et al. Laryngeal penetration and aspiration in individuals with stable COPD. Respirology 2011;16:269-275.
37. Gross RD, Atwood CW Jr, Ross SB, et al. The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:559-565.
38. Clayton NA, Carnaby GD, Peters MJ, Ing AJ. Impaired laryngopharyngeal sensitivity in patients with COPD: The association with swallow function. Int J Speech Lang Pathol 2014. [Epub ahead of print] A study reporting reduced laryngopharyngeal mechanosensitivity and impaired swallowing function in COPD patients.
39. Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest 2010;137:326-332.
40. Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:139-150. A review on pathogenesis, clinical consequences, and therapeutic options of airway mucus accumulation in COPD.
41. Hessel J, Heldrich J, Fuller J, et al. Intraflagellar transport gene expression associated with short cilia in smoking and COPD. PLoS One 2014;9:e85453.
42. Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:228-237. A review on epidemiology, clinical consequences, pathophysiology, and current therapies of chronic bronchitis.
43. Angelis N, Porpodis K, Zarogoulidis P, et al. Airway inflammation in chronic obstructive pulmonary disease. J Thorac Dis 2014;6(Suppl 1):S167-S172. A review of available noninvasive techniques for assessment of inflammatory mediators of COPD.
44. Berenson CS, Kruzel RL, Eberhardt E, Sethi S. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J Infect Dis 2013;208:2036-2045. An experimental study pointing out defective alveolar macrophage phagocytosis of respiratory bacteria in COPD.
45. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest 2012;141:1055-1062.
46. Berenson CS, Kruzel RL, Eberhardt E, et al. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations. Thorax 2014. [Epub ahead of print] An experimental study observing impaired innate responses of COPD alveolar macrophages to respiratory pathogens, mediated by impaired TLR responses, underlying a propensity for exacerbations in COPD.
47. Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2013;48:531-539. A review of neutrophilic inflammation features in COPD.
48. Herzog R, Cunningham-Rundles S. Immunologic impact of nutrient depletion in chronic obstructive pulmonary disease. Curr Drug Targets 2011;12:489-500.
49. Patterson CM, Morrison RL, D'Souza A, et al. Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in mice. Respir Res 2012;13:40.
50. Hogg JC, Chu FSF, Tan WC, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med 2007;176:454-459.
51. Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 2007;4:e115.
52. Yawn BP, Li Y, Tian H, et al. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J Chron Obstruct Pulmon Dis 2013;8:295-304. A retrospective analysis of a cohort of COPD patients assessing the association between inhaled corticosteroids use and dose, and risk of pneumonia.
53. Suissa S, Patenaude V, Lapi F, Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013;68:1029-1036. A study on a large cohort of COPD patients evaluating the impact of inhaled corticosteroids on risk of serious pneumonia.
54. Calverley PM, Stockley RA, Seemungal TA, et al. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest 2011;139:505-512.
55. Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-647.
56. Ranzani OT, Ferrer M, Esperatti M, et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med 2012;40:2552-2561.
57. Hadda V, Khilnani GC, Dubey G, et al. Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation. Lung India 2014;31:4-8. A retrospective study on the impact of VAP on outcome of patients with COPD exacerbation.
58. Lisboa T, Diaz E, Sa-Borges M, et al. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 2008;134:1208-1216.
59. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993;104:1230-1235.
60. Lightowler JV, Wedzicha JA, Elliott MW, Ram FSF. Noninvasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis. BMJ 2003;326:185.
61. Girou E, Brun-Buisson C, Taillé S, et al. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA 2003;290:2985-2991.
62. Burns KEA, Meade MO, Premji A, Adhikari NKJ. Noninvasive ventilation as a weaning strategy for mechanical ventilation in adults with respiratory failure: a Cochrane systematic review. CMAJ 2014;186:E112-E122. A review of randomized trials on outcomes of noninvasive versus invasive weaning in adults on mechanical ventilation.
63. Terzi N, Normand H, Dumanowski E, et al. Noninvasive ventilation and breathing-swallowing interplay in chronic obstructive pulmonary disease. Crit Care Med 2014;42:565-573. A prospective study investigating breathing-swallowing interactions in exacerbated COPD patients requiring noninvasive mechanical ventilation.
64. Baudry T, Ader F. Non-invasive mechanical ventilation to prevent ICU-acquired infection. Infect Disord Drug Targets 2011;11:384-388.
65. Sasaki T, Nakayama K, Yasuda H, et al. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 2009;57:1453-1457.
66. Khorvash F, Abbasi S, Meidani M, et al. The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients. Adv Biomed Res 2014;3:52. A prospective randomized study comparing pantoprazole with sucralfate in incidence of VAP.